Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B

Clinical trial NCT04071379 · COMPLETED

Trial details

NCT number: NCT04071379
Sponsor: PT Bio Farma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immunogenicity Safety

Start date: 2020-10-13
Primary completion: 2021-04-06
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.